AstraZeneca PLC (Cambridge, UK). 2024 revenue ~$50B. Oncology: Tagrisso, Enhertu (ADC). Rare disease: Alexion. Respiratory: Symbicort. API synthesis at Macclesfield, UK and Wuxi, China.
12:40:39 AM · Jul 9, 2026
Sign in to reply and join the conversation.